HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.

Abstract
Intracellular therapeutic targets that define tumor immunosuppression in both tumor cells and T cells remain intractable. Here, we have shown that administration of a covalently linked siRNA to an aptamer (apt) that selectively binds cytotoxic T lymphocyte-associated antigen 4 (CTLA4(apt)) allows gene silencing in exhausted CD8⁺ T cells and Tregs in tumors as well as CTLA4-expressing malignant T cells. CTLA4 expression was upregulated in CD8⁺ T cells in the tumor milieu; therefore, CTLA4(apt) fused to a STAT3-targeting siRNA (CTLA4(apt)-STAT3 siRNA) resulted in internalization into tumor-associated CD8⁺ T cells and silencing of STAT3, which activated tumor antigen-specific T cells in murine models. Both local and systemic administration of CTLA4(apt)-STAT3 siRNA dramatically reduced tumor-associated Tregs. Furthermore, CTLA4(apt)-STAT3 siRNA potently inhibited tumor growth and metastasis in various mouse tumor models. Importantly, CTLA4 expression is observed in T cells of patients with blood malignancies, and CTLA4(apt)-STAT3 siRNA treatment of immunodeficient mice bearing human T cell lymphomas promoted tumor cell apoptosis and tumor growth inhibition. These data demonstrate that a CTLA4(apt)-based siRNA delivery strategy allows gene silencing in both tumor-associated T cells and tumor cells and inhibits tumor growth and metastasis.
AuthorsAndreas Herrmann, Saul J Priceman, Piotr Swiderski, Maciej Kujawski, Hong Xin, Gregory A Cherryholmes, Wang Zhang, Chunyan Zhang, Christoph Lahtz, Claudia Kowolik, Steve J Forman, Marcin Kortylewski, Hua Yu
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 124 Issue 7 Pg. 2977-87 (Jul 2014) ISSN: 1558-8238 [Electronic] United States
PMID24892807 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Aptamers, Nucleotide
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Ctla4 protein, mouse
  • RNA, Small Interfering
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Stat3 protein, mouse
Topics
  • Animals
  • Aptamers, Nucleotide (administration & dosage, genetics)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • CTLA-4 Antigen (genetics)
  • Cell Line, Tumor
  • Gene Silencing
  • Humans
  • Immunotherapy, Adoptive (methods)
  • Lymphocytes, Tumor-Infiltrating (immunology, metabolism)
  • Lymphoma, T-Cell (immunology, therapy)
  • Melanoma, Experimental (immunology, therapy)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Nude
  • RNA, Small Interfering (administration & dosage, genetics)
  • STAT3 Transcription Factor (antagonists & inhibitors, genetics)
  • T-Lymphocytes, Regulatory (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: